US EditionPublished • loading... • Updated
Concept Life Sciences Appoints Dr Adam Davenport as CSO to Strengthen Leadership in Integrated Drug Discovery
Dr Adam Davenport brings 25 years of experience and leadership to enhance Concept Life Sciences' drug discovery, which has advanced 29 candidates to clinical trials.
Summary by Benzinga
4 Articles
4 Articles
News MedicalReposted by 
News-Medical.net
News-Medical.netDr Adam Davenport appointed as CSO to strengthen leadership in integrated drug discovery
We are pleased to announce the appointment of Dr Adam Davenport as Chief Scientific Officer to spearhead our integrated drug discovery offering for biotech and pharmaceutical partners.
·United States
Read Full Article
Concept Life Sciences Appoints Dr Adam Davenport as CSO to Strengthen Leadership in Integrated Drug Discovery
CHAPEL-EN-LE-FRITH, United Kingdom, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Concept Life Sciences, a leading global contract research organization (CRO) specialising in integrated drug discovery, development, and analytical services, today announced the appointment of Dr Adam Davenport as Chief Scientific Officer to spearhead its integrated drug discovery offering for biotech and pharmaceutical partners. Bringing over 25 years of hands-on experience i…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources4
Leaning Left0Leaning Right1Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
C 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium
